Investment Management Associates Inc. ADV Acquires 7,616 Shares of Molina Healthcare, Inc $MOH

Investment Management Associates Inc. ADV increased its holdings in shares of Molina Healthcare, Inc (NYSE:MOH) by 3.4% during the first quarter, Holdings Channel.com reports. The fund owned 233,152 shares of the company’s stock after purchasing an additional 7,616 shares during the quarter. Molina Healthcare accounts for about 7.4% of Investment Management Associates Inc. ADV’s holdings, making the stock its 3rd biggest position. Investment Management Associates Inc. ADV’s holdings in Molina Healthcare were worth $31,079,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC boosted its holdings in Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after purchasing an additional 2,008,458 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in shares of Molina Healthcare by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock worth $376,831,000 after purchasing an additional 201,772 shares during the period. Invesco Ltd. increased its holdings in shares of Molina Healthcare by 24.2% during the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after purchasing an additional 329,679 shares during the period. Victory Capital Management Inc. raised its position in shares of Molina Healthcare by 46.4% in the fourth quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock valued at $244,796,000 after buying an additional 447,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Molina Healthcare by 23.7% in the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock valued at $185,929,000 after buying an additional 267,121 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. JPMorgan Chase & Co. increased their price target on Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a research report on Monday, June 8th. Royal Bank Of Canada lifted their price objective on Molina Healthcare from $216.00 to $248.00 and gave the company a “sector perform” rating in a report on Thursday, July 9th. Robert W. Baird upped their target price on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Sanford C. Bernstein set a $286.00 target price on Molina Healthcare in a report on Monday, July 13th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $129.00 price target on shares of Molina Healthcare in a research report on Friday, April 24th. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $207.06.

Molina Healthcare Stock Performance

NYSE MOH opened at $225.66 on Monday. The firm’s 50 day simple moving average is $203.43 and its 200 day simple moving average is $175.58. The firm has a market capitalization of $11.76 billion, a price-to-earnings ratio of 66.76 and a beta of 0.74. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $244.89.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. During the same period in the previous year, the business earned $6.08 earnings per share. The company’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, research analysts expect that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.44% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.